Investigation of the Characteristics of Chronic Pain Developing After COVID-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

776 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-03-24

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Data on pain after COVID-19 were generally collected from hospitalized patients and only include information on acute pain conditions. However, the characteristics of the chronic pain experienced after COVID-19 are unknown. For this reason, the treatment and recommendations for patients who present with chronic pain after COVID-19 are not clear. Our goal is to determine the characteristics and risk factors of chronic pain developing in COVID-19 patients and to create specific treatment recommendations for these patient groups with further studies.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effects of the COVID-19 Pandemic on Fibromyalgia Patients

NCT04730934

Fibromyalgia Chronic Low-back Pain

COMPLETED

The Effects of Covid-19 Pandemic on The Patients With Fibromyalgia

NCT04686578

Fibromyalgia Covid-19 Fear Covid-19 Anxiety +3 more

UNKNOWN

Anxiety, Depression, and Quality of Life in Patients With Fibromyalgia During the Coronavirus Disease 2019 Pandemic

NCT05410808

Fibromyalgia Coronavirus Disease 2019 Pandemic

COMPLETED

Fibromyalgia Syndrome on Patients With Chronic Migraine

NCT05381012

Chronic Migraine, Headache Fibromyalgia Syndrome Chronic Pain Syndrome +2 more

COMPLETED NA

Influence of Trauma on Pain Area and Widespreadness in Chronic Pain Patients

NCT05190367

Chronic Pain Trauma

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Data on pain developing after COVID-19 were generally collected from hospitalized patients and only include information on acute pain conditions seen after the ilness. It is noteworthy that headache and musculoskeletal pain were seen common in first few weeks. However, the characteristics (mechanical, inflammatory, central sensitization, anxiety-related, etc.) of the chronic pain experienced are unknown. For this reason, the treatment and recommendations for patients who present with chronic pain after COVID-19 are not clear. Our goal is to determine the characteristics and risk factors of chronic pain developing in COVID-19 patients and to create specific treatment recommendations for these patient groups with further studies.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid19 Coronavirus Chronic Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Being over the age of 18
2. SARS-CoV-2 infection demonstrated with the PCR test (testing date irrelevant)
3. Pain developed or increased after having COVID-19